Back to search

Article

Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failure

2021-08-21

Abstract excerpt

<h4>Introduction</h4> Nitric Oxide (NO) is an endogenous vasodilator that is synthesized by the vascular endothelium. Due to its vasodilatory effect and short half-life, the use of NO as an exogenous inhaled medication (iNO) to target the pulmonary vasculature, in conditions with increased pulmonary vascular resistance, has been studied. The use of iNO in patients with ARDS secondary to COVID-19 has therapeutic im...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2af65c9a-3e9d-595b-97bf-4972f47e7d51
DOI
10.1101/2021.08.19.21262314
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failureDOI 10.1101/2021.08.19.21262314
Select a neighboring publication to make it the new centre.